Skip to main content
UniHealth

Doctor search

Monikankana A Alem, MD

Family Practice · Sacramento

NPI 1275095259

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2
Since medical school
7 years
University of Southern California Keck School of Medicine, 2019

Offices

2 locations · Regents of the Univ of CA · Cares Community Health

Looking this up.

Hospitals listed: University of California Davis Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Alem’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence A179554 · Current

Licensed to practise in California · since 2022 · expires 2028-08-31 · University of Southern California Keck School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Family Medicine - Family Medicine

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • University of California Davis Medical CenterSacramento, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UC Davis Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 1.94 (1.18 to 2.71) · 3,010 cases, Jul 2022 – Jun 2024Worse than the national rate — MRSA Bacteremia: 1.564, Oct 2024 – Sep 2025Worse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 6.7 (5.6 to 8) · 1,134 cases, Jan 2024 – Dec 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.6 (10.9 to 14.5) · 1,134 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 127.46 (95.81 to 159.1) · 281 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.18 (0 to 0.57) · 12,625 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.677, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.713, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,436 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for University of California Davis Medical Center

Behind the star rating — Deaths: 4 better, 4 the same, 0 worse of 8 measures. Safety: 0 better, 7 the same, 1 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at University of California Davis Medical Center
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.94 (1.18 to 2.71) · 3,010 casesWorseJul 2022 – Jun 2024
MRSA BacteremiaInfections1.564WorseOct 2024 – Sep 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.7 (5.6 to 8) · 1,134 casesWorseJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.6 (10.9 to 14.5) · 1,134 casesWorseJan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths127.46 (95.81 to 159.1) · 281 casesBetterJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.18 (0 to 0.57) · 12,625 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.677BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.713BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.7 to 1) · 2,436 casesBetterJan 2024 – Dec 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.98 (0.78 to 1.19)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.2 · 82 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.2 · 165 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.2 · 115 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.7 · 662 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.1 · 463 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 406 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.9 · 4,328 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.22 (0.05 to 0.39) · 13,828 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.3 (0.13 to 0.46) · 14,152 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.29 (2.92 to 5.66) · 4,920 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.78 (0.46 to 3.09) · 2,250 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.07 (1.06 to 3.09) · 4,696 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths9.46 (5.18 to 13.75) · 2,102 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.35 (3.74 to 8.96) · 2,191 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.48 (1.19 to 3.77) · 1,169 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.3 · 127 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.826No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.899No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.669No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.2 · 131 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits21.2 · 751 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-25.8 · 127 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits24.1 · 758 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits23.6 · 477 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits17.6 · 469 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits5.7 · 140 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 65 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits18.3 · 203 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits11.8 (9.4 to 14.9) · 2,643 casesNo differentJan 2022 – Dec 2024

What patients said (2,768 patients answered, 18% of those asked)

Patient survey stars by topic at University of California Davis Medical Center
Cleanliness2
Nurse communication3
Doctor communication3
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness1
Recommend hospital4
Share of patients giving the best answer at University of California Davis Medical Center
Room was "always" clean61%
Nurses "always" communicated well76%
Doctors "always" communicated well78%
Staff "always" explained60%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand72%
Doctors "always" listened carefully76%
Doctors "always" treated them with courtesy and respect85%
Patients who gave a rating of "9" or "10" (high)68%
Staff "always" explained new medications73%
Nurses "always" explained things so they could understand71%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night37%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects47%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$14,383

Medicare paid this office $14,383 for 110 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes25$5,030$64
Short return visit (20+ min)39$1,927$45
Return visit (30+ min)33$1,759$50
Hospital discharge day management, 30 minutes or less17$1,126$66
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's25$348$12

Who their Medicare patients are

110 Original Medicare patients in 2024. Average age 69 · Under 65 32% · 85 and older 11% · Women 66% · Also on Medicaid 69% · Health risk score 2.31. Sicker patients than 9 in 10 peers; the typical family practice clinician is at 1.13.

Conditions among them: High blood pressure 71% · Diabetes 45% · Chronic kidney disease 38% · Coronary heart disease 33% · Depression 28% · Heart failure 27% · COPD 25% · Dementia 22% · Stroke 18% · Atrial fibrillation 16% · Cancer 15%.

The office billed $85,260, Medicare allowed $19,539 and paid $14,383; for 262 services of 24 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024110262692.31$85,260$14,383
2023211310692.00$117,557$15,789
202299127681.78$50,134$8,519

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 4 services

Original Medicare services billed in 2023
Return visit (30+ min)87$4,988$50
Short return visit (20+ min)94$4,029$40
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes14$1,802$64
Short return visit11$384$35

2022: 2 services

Original Medicare services billed in 2022
Return visit (30+ min)38$3,303$81
Short return visit (20+ min)41$2,283$53

Medicaid work

$474,091 in 2024

Medicaid paid $474,091 for 4,010 billed services this clinician did in 2024, up to 158 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Clinic visit/encounter, all-inclusive1,393$468,555
Return visit (30+ min)1,218$3,159
Short return visit (20+ min)899$1,476
Long return visit (40+ min)101$835
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)257$66
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)19$0
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose24$0
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 50 mcg/0.5 mL dosage, for intramuscular use24$0
Administration of patient-focused health risk assessment instrument (eg, health hazard appraisal) with scoring and documentation, per standardized instrument75$0
Medicaid work by year
20244,0109158$474,091
20232,09910132$226,064
202299337$12,651
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Clinic visit/encounter, all-inclusive758$224,444
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 50 mcg/0.5 mL dosage, for intramuscular use35$680
Return visit (30+ min)295$522
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose37$200
Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use55$76
Short return visit (20+ min)700$72
Long return visit (40+ min)48$57
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)141$13
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)15$0
Short return visit15$0

2022

Largest Medicaid services in 2022
Clinic visit/encounter, all-inclusive45$12,651
Short return visit (20+ min)41$0
Hospital outpatient clinic visit for assessment and management of a patient13$0

Drugs they prescribed that Part D paid

$139,449

Pharmacies billed $139,449 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 8% of their Part D prescriptions (86 of 1,097) in 2024. A higher opioid share than 9 in 10 peers; the typical family practice clinician is at 2%. Long-acting opioids: 22% of their opioid prescriptions.

884 generic and fewer than 11 brand-name prescriptions · $139,449 in drug cost · 11 antibiotic prescriptions.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Jardiance22$26,145$1,188
Mounjaro12$10,923$910
Hydrocodone-Acetaminophen58$1,527$26
Gabapentin42$948$23
Albuterol Sulfate Hfa24$868$36
See all 27 drugs
Every Part D drug this clinician prescribed
Jardiance22$26,145$1,188
Mounjaro12$10,923$910
Hydrocodone-Acetaminophen58$1,527$26
Gabapentin42$948$23
Albuterol Sulfate Hfa24$868$36
Rosuvastatin14$541$39
Atorvastatin69$514$7
Levothyroxine32$409$13
Metformin Hcl Er11$299$27
Losartan47$293$6
Cyclobenzaprine18$290$16
Pregabalin13$283$22
Lisinopril31$226$7
Memantine11$204$19
Amlodipine Besylate42$182$4
Famotidine23$156$7
Omeprazole22$155$7
Tamsulosin25$137$5
Sertraline18$131$7
Metformin21$73$3
Simvastatin11$69$6
Ibuprofen16$65$4
Prednisone11$56$5
Furosemide19$53$3
Hydrochlorothiazide18$48$3
Alendronate13$42$3
Donepezil13$37$3

Year by year

Part D prescribing by year
20241,0971768% (86)None$139,449
20238821975% (48)None$185,409
202220961NoneNone$26,471
2021485743% (16)None$57,648
20207629NoneNone$5,003

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 19 drugs

Part D drugs prescribed in 2023
Jardiance31$36,519$1,178
Trulicity16$24,219$1,514
Lantus Solostar11$2,774$252
Atorvastatin55$1,068$19
Gabapentin29$982$34
Hydrocodone-Acetaminophen22$972$44
Ventolin Hfa12$745$62
Venlafaxine Hcl Er11$474$43
Levothyroxine25$467$19
Sertraline13$403$31
Losartan25$376$15
Amlodipine Besylate24$373$16
Famotidine22$310$14
Lisinopril22$257$12
Ibuprofen26$228$9
Clopidogrel14$213$15
Metformin19$181$10
Fluticasone Propionate13$174$13
Hydrochlorothiazide29$121$4

2022: 2 drugs

Part D drugs prescribed in 2022
Gabapentin11$135$12
Lisinopril16$58$4

2021: 8 drugs

Part D drugs prescribed in 2021
Atorvastatin46$1,003$22
Hydrocodone-Acetaminophen16$521$33
Levothyroxine12$337$28
Amlodipine Besylate41$325$8
Gabapentin14$253$18
Lisinopril25$190$8
Simvastatin12$122$10
Metoprolol12$29$2

Professional record

NPI
1275095259
Licence
CA A179554California A179554: Current · expires 2028-08-31
Trained
University of Southern California Keck School of Medicine, 2019 · 7 years ago
Group
Regents of the Univ of CA · Cares Community Health
Gender
Female
More record details
Sole proprietor
Yes
Taxonomy
Family medicine (207Q00000X); Student in a training program (390200000X)
Mailing address
4860 Y St Ste 1600, Sacramento, CA, 95817
NPI first listed
2019-04-01
NPI last updated
2023-02-02
NPI record certified
2023-02-02

This is when the NPI record was last certified, not a medical board exam.